Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 128, Issue 24
December 15 2016
Issue Cover

Table of Contents

BLOOD FLASHBACK

Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood. 1977;50(3):481-492.
View Articletitled, Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. <em>Blood</em>. 1977;50(3):<span class="related-article">481-492</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Measure for measure: minimal residual disease in CLL
Clinical Trials & Observations
Richard F. Little,Lisa M. McShane
View Articletitled, Measure for measure: minimal residual disease in CLL
INSIDE BLOOD COMMENTARY
Metformin: treating the cause of Fanconi anemia?
Gerry P. Crossan
View Articletitled, Metformin: treating the cause of Fanconi anemia?
INSIDE BLOOD COMMENTARY
Macrophage precursors PLASTed INto alveolar space
Martin Guilliams,Bart N. Lambrecht
View Articletitled, Macrophage precursors PLASTed INto alveolar space
INSIDE BLOOD COMMENTARY
Neighborhood imbalances: overcoming MCL drug resistance
John M. Pagel
View Articletitled, Neighborhood imbalances: overcoming MCL drug resistance
INSIDE BLOOD COMMENTARY
Interferon-induced thrombotic microangiopathy
James N. George
View Articletitled, Interferon-induced thrombotic microangiopathy
INSIDE BLOOD COMMENTARY
Polyphosphate strikes back
Coen Maas
View Articletitled, Polyphosphate strikes back

PERSPECTIVE

Next-generation multiple myeloma treatment: a pharmacoeconomic perspective
S. Vincent Rajkumar,Jean Luc Harousseau
View Articletitled, Next-generation multiple myeloma treatment: a pharmacoeconomic perspective

REVIEW ARTICLE

To B1a or not to B1a: do hematopoietic stem cells contribute to tissue-resident immune cells?
Anna E. Beaudin,E. Camilla Forsberg
View Articletitled, To B1a or not to B1a: do hematopoietic stem cells contribute to tissue-resident immune cells?

CLINICAL TRIALS AND OBSERVATIONS

Minimal residual disease is an independent predictor for 10-year survival in CLL
Clinical Trials & Observations Brief Report
Marwan Kwok,Andy C. Rawstron,Abraham Varghese,Paul A. S. Evans,Sheila J. M. O’Connor,Chi Doughty,Darren J. Newton,Paul Moreton,Peter Hillmen
View Articletitled, Minimal residual disease is an independent predictor for 10-year survival in CLL
Supplemental data

HEMATOPOIESIS AND STEM CELLS

Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice
Qing-Shuo Zhang,Weiliang Tang,Matthew Deater,Ngoc Phan,Andrea N. Marcogliese,Hui Li,Muhsen Al-Dhalimy,Angela Major,Susan Olson,Raymond J. Monnat, Jr,Markus Grompe
View Articletitled, Metformin improves defective hematopoiesis and delays tumor formation in Fanconi anemia mice
Supplemental data

IMMUNOBIOLOGY

Alveolar macrophage development in mice requires L-plastin for cellular localization in alveoli
Elizabeth M. Todd,Julie Y. Zhou,Taylor P. Szasz,Lauren E. Deady,June A. D’Angelo,Matthew D. Cheung,Alfred H. J. Kim,Sharon Celeste Morley
View Articletitled, Alveolar macrophage development in mice requires L-plastin for cellular localization in alveoli
Supplemental data

LYMPHOID NEOPLASIA

An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL
Yun Mai,J. Jessica Yu,Boris Bartholdy,Zijun Y. Xu-Monette,Esther E. Knapp,Fei Yuan,Hongshan Chen,B. Belinda Ding,Zhihua Yao,Bhaskar Das,Yiyu Zou,Ken He Young,Samir Parekh,B. Hilda Ye
View Articletitled, An oxidative stress-based mechanism of doxorubicin cytotoxicity suggests new therapeutic strategies in ABC-DLBCL
Supplemental data
Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma
David Chiron,Céline Bellanger,Antonin Papin,Benoit Tessoulin,Christelle Dousset,Sophie Maiga,Anne Moreau,Julie Esbelin,Valérie Trichet,Selina Chen-Kiang,Philippe Moreau,Cyrille Touzeau,Steven Le Gouill,Martine Amiot,Catherine Pellat-Deceunynck
View Articletitled, Rational targeted therapies to overcome microenvironment-dependent expansion of mantle cell lymphoma
Supplemental data

MYELOID NEOPLASIA

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients
Clinical Trials & Observations Brief Report
Kate Stringaris,David Marin,A. John Barrett,Robert Hills,Catherine Sobieski,Kai Cao,Jerome G. Saltarrelli,May Daher,Hila Shaim,Nathaniel Smith,David Linch,Rosemary Gale,Christopher Allen,Takuya Sekine,Rohtesh Mehta,Richard Champlin,Elizabeth J. Shpall,Hagop Kantarjian,Guillermo Garcia-Manero,Katayoun Rezvani
View Articletitled, KIR gene haplotype: an independent predictor of clinical outcome in MDS patients
Supplemental data

PLATELETS AND THROMBOPOIESIS

Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature
David Kavanagh,Sarah McGlasson,Alexa Jury,Jac Williams,Neil Scolding,Chris Bellamy,Claudia Gunther,Diane Ritchie,Daniel P. Gale,Yashpal S. Kanwar,Rachel Challis,Holly Buist,James Overell,Belinda Weller,Oliver Flossmann,Mark Blunden,Eric P. Meyer,Thomas Krucker,Stephen J. W. Evans,Iain L. Campbell,Andrew P. Jackson,Siddharthan Chandran,David P. J. Hunt
View Articletitled, Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature
Supplemental data

THROMBOSIS AND HEMOSTASIS

Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity
Joanne L. Mitchell,Ausra S. Lionikiene,Georgi Georgiev,Anja Klemmer,Chelsea Brain,Paul Y. Kim,Nicola J. Mutch
View Articletitled, Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity
Supplemental data

TRANSPLANTATION

DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease
Hidekazu Nishikii,Byung-Su Kim,Yasuhisa Yokoyama,Yan Chen,Jeanette Baker,Antonio Pierini,Maite Alvarez,Melissa Mavers,Kristina Maas-Bauer,Yuqiong Pan,Shigeru Chiba,Robert S. Negrin
View Articletitled, DR3 signaling modulates the function of Foxp3<sup>+</sup> regulatory T cells and the severity of acute graft-versus-host disease
Supplemental data

LETTERS TO BLOOD

Gene-corrected human Munc13-4–deficient CD8+ T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice
Tayebeh Soheili,Julie Rivière,Ida Ricciardelli,Amandine Durand,Els Verhoeyen,Anne-Céline Derrien,Chantal Lagresle-Peyrou,Geneviève de Saint Basile,François-Loïc Cosset,Persis Amrolia,Isabelle André-Schmutz,Marina Cavazzana
View Articletitled, Gene-corrected human Munc13-4–deficient CD8<sup>+</sup> T cells can efficiently restrict EBV-driven lymphoproliferation in immunodeficient mice
Supplemental data
Somatic mosaicism in chronic myeloid leukemia in remission
Kinuko Mitani,Yasunobu Nagata,Ko Sasaki,Kenichi Yoshida,Kenichi Chiba,Hiroko Tanaka,Yuichi Shiraishi,Satoru Miyano,Hideki Makishima,Yukitsugu Nakamura,Yuka Nakamura,Motoshi Ichikawa,Seishi Ogawa
View Articletitled, Somatic mosaicism in chronic myeloid leukemia in remission
Supplemental data

BLOOD WORK

An unusual presentation of secondary AML
Michelle T. Harrison,Keith Gelly
View Articletitled, An unusual presentation of secondary AML
Flowers blossoming in the desert heat
David A. Nolte,Maria A. Proytcheva
View Articletitled, Flowers blossoming in the desert heat

ERRATUM

Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012;120(22):4304-4310.
View Articletitled, Thornburg CD, Files BA, Luo Z, et al. Impact of hydroxyurea on clinical events in the BABY HUG trial. <em>Blood.</em> 2012;120(22):4304-4310.
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals